Medis Technologies Schedules Fourth Quarter and Year-End Financial Results and Conference Call.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Medis Technologies Ltd. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : MDTL MDTL Medis Technologies, Ltd (stock symbol) MDTL Montana Defense Trial Lawyers Association ) ("Medis") announced today that it will issue its financial results for the fourth quarter and year ended December 31, 2004 on Thursday, March 17, 2005. Management will also conduct a conference call that morning at 10:00 a.m. Eastern Time to discuss these results and the current status of its business operations Business operations are those activities involved in the running of a business for the purpose of producing value for the stakeholders. Compare business processes. The outcome of business operations is the harvesting of value from assets . Interested parties may participate in the call by dialing 888-743-9491 (Domestic) or 706-679-0886 (International) approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Medis conference call. A recorded replay of the call will be available until 5:00 p.m. Eastern Time on Tuesday, March 22, 2005. Listeners may dial 800-642-1687 (Domestic) or 706-645-9291 (International) and use the code 4523307 for the replay. The Company also noted that it will be demonstrating its operational fuel cell Power Pack products on March 16, 2005 in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The presentation will be held at the Marriott Marquis Hotel at 1535 Broadway (44th street and Broadway) at 4:30 PM ET. It is expected to end around 6:30 PM ET. Medis Technologies is involved in the development of highly advanced proprietary technology products primarily related to sources of clean energy for the 21st Century. Medis' primary focus is on direct liquid fuel cell technology. Its business strategy is to license or sell its technologies to, or enter into joint ventures with, large international corporations or sell its products to end users through retail outlets and service providers. In addition to its fuel cell technology, Medis' product pipeline, in varying stages of development, includes inherently conductive polymers, the toroidal engine and compressor and stirling cycle system. Medis has also developed the CellScan with many potential applications relating to disease diagnostics and chemo che·mo n. Chemotherapy or a chemotherapeutic treatment. sensitivity. This press release may contain forward-looking statements, which are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such forward-looking statements involve risk and uncertainties, including, but not limited to, the successful completion of product development, the success of product tests, commercialization risks, availability of financing and results of financing efforts. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC. This press release is available on Medis' web site at www.medistechnologies.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion